MRC Global (MRC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
DNOW and MRC Global have agreed to merge, creating a combined company with an estimated enterprise value of $3.0 billion, with DNOW stockholders owning 56.5% and MRC Global stockholders 43.5% of the new entity on a fully diluted basis.
The merger will be executed in two steps: Merger Sub merges into MRC Global, then MRC Global merges into LLC Sub, a DNOW subsidiary, making the combined company a wholly owned subsidiary of DNOW.
Each MRC Global share will be converted into 0.9489 shares of DNOW common stock, with cash paid for fractional shares; MRC Global shares will be delisted from the NYSE.
The boards of both companies unanimously recommend approval of the merger and related proposals.
Voting matters and shareholder proposals
DNOW stockholders will vote on the issuance of DNOW shares to MRC Global stockholders and on the potential adjournment of the DNOW special meeting.
MRC Global stockholders will vote on the adoption of the merger agreement, a non-binding advisory vote on executive compensation related to the merger, and the potential adjournment of the MRC Global special meeting.
Approval of the DNOW stock issuance and MRC Global merger proposals is required for the merger to proceed; adjournment and compensation advisory votes are not conditions to closing.
Board of directors and corporate governance
The combined company’s board will expand to ten members, including two directors from MRC Global’s board selected by DNOW.
DNOW’s current executive officers are expected to continue in their roles post-merger.
Latest events from MRC Global
- Q2 2024 delivered record margins, strong cash flow, and historic low net debt.MRC
Q2 20242 Feb 2026 - Sales and earnings declined, but robust cash flow drove higher full-year guidance.MRC
Q3 202416 Jan 2026 - Record cash flow, margin strength, and a $125M buyback set the stage for 2025 growth.MRC
Q4 202425 Dec 2025 - Annual meeting to address director elections, executive pay, auditor, and governance updates.MRC
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay, and auditor ratification for 2025.MRC
Proxy Filing1 Dec 2025 - Q1 revenue rose sequentially, backlog grew, and a $125M buyback began despite Canada loss.MRC
Q1 202521 Nov 2025 - All-stock merger forms a $3B global leader with $70M synergies and double-digit EPS growth.MRC
M&A Announcement13 Nov 2025 - Q3 2025 revenue fell 15% to $678M, with ERP issues and sector declines driving a net loss.MRC
Q3 20255 Nov 2025 - Q2 2025 featured a pending DNOW merger, flat revenue, and strong sequential growth.MRC
Q2 20256 Aug 2025